Neural network dose prediction for rectal spacer stratification in dose‐escalated prostate radiotherapy
Open Access
- 11 March 2022
- journal article
- research article
- Published by Wiley in Medical Physics
- Vol. 49 (4) , 2172-2182
Abstract
Purpose To develop a knowledge-based decision-support system capable of stratifying patients for rectal spacer (RS) insertion based on neural network predicted rectal dose, reducing the need for time- and resource-intensive radiotherapy (RT) planning. Methods Forty-four patients treated for prostate cancer were enrolled into a clinical trial (NCT03238170). Dose-escalated prostate RT plans were manually created for 30 patients with simulated boost volumes using a conventional treatment planning system (TPS) and used to train a hierarchically dense 3D convolutional neural network to rapidly predict RT dose distributions. The network was used to predict rectal doses for 14 unseen test patients, with associated toxicity risks calculated according to published data. All metrics obtained using the network were compared to conventionally planned values. Results The neural network stratified patients with an accuracy of 100% based on optimal rectal dose-volume histogram constraints and 78.6% based on mandatory constraints. The network predicted dose-derived grade 2 rectal bleeding risk within 95% confidence limits of -1.9% to +1.7% of conventional risk estimates (risk range 3.5%-9.9%) and late grade 2 fecal incontinence risk within -0.8% to +1.5% (risk range 2.3%-5.7%). Prediction of high-resolution 3D dose distributions took 0.7 s. Conclusions The feasibility of using a neural network to provide rapid decision support for RS insertion prior to RT has been demonstrated, and the potential for time and resource savings highlighted. Directly after target and healthy tissue delineation, the network is able to (i) risk stratify most patients with a high degree of accuracy to prioritize which patients would likely derive greatest benefit from RS insertion and (ii) identify patients close to the stratification threshold who would require conventional planning.Keywords
This publication has 22 references indexed in Scilit:
- Who will benefit most from hydrogel rectum spacer implantation in prostate cancer radiotherapy? A model-based approach for patient selectionRadiotherapy and Oncology, 2016
- Knowledge-based prediction of three-dimensional dose distributions for external beam radiotherapyMedical Physics, 2015
- Quantifying Unnecessary Normal Tissue Complication Risks due to Suboptimal Planning: A Secondary Study of RTOG 0126International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2015
- Boosting imaging defined dominant prostatic tumors: A systematic reviewRadiotherapy and Oncology, 2013
- Variation in external beam treatment plan quality: An inter-institutional study of planners and planning systemsPractical Radiation Oncology, 2012
- Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trialTrials, 2011
- Radiation Dose–Volume Effects in Radiation-Induced Rectal InjuryInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Factors Predictive of Tumor Recurrence and Survival After Initial Complete Response of Esophageal Squamous Cell Carcinoma to Definitive ChemoradiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Potential improvements in the therapeutic ratio of prostate cancer irradiation: dose escalation of pathologically identified tumour nodules using intensity modulated radiotherapyBritish Journal of Radiology, 2002
- Zonal Distribution of Prostatic AdenocarcinomaAmerican Journal of Surgical Pathology, 1988